Clinical Trial

A Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multiparameter MRI

Recruiting
View on ClinicalTrials.gov →
Summary
This project aims to use multi-temporal, multi-parameter MRI features, blood biomarkers, and clinical indicators to accurately assess pseudoprogression following immunotherapy in rectal cancer.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2026-01-25; most recent amendment 2026-04-21.
Status change: Not Yet Recruiting → Recruiting 2026-01-31
Trial Details
NCT Number NCT07381322
Lead Sponsor Peiyi Xie
Collaborators: Xinyi City People's Hospital
Conditions Rectal Cancer
Enrollment 300 participants
Start Date 2026-02-01
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-23